Home » Blog » As one of the pioneers in the ICL industry

As one of the pioneers in the ICL industry

As one of the pioneers Aidikang has significant competitive advantages and market position in the industry. In recent years,

in the rapidly developing mical and health industry, Aidikang has emerg with its strength and

gradually become one of the major players in the fax lists market. Relying on advanc testing technology, a

complete service system and an extensive business layout, the company continues to increase its market share and brand influence.

The cooperation with the Capital Mical University Clinical Examination Center has undoubtly inject

new impetus and vitality into the development of Aidikang. The integration and sharing of resources

between the two parties will further enhance Aidikang’s technical level and service capabilities, and provide strong support for the company’s sustainable development and business innovation.

Against the backdrop of an increasingly aging global population

Mical services have become a primary area of ​​concern. Aidikang’s professional testing capabilities in

six key disease areas and its continuously improving competitive advantages through technological

innovation and service optimization have enabl it to gain good development opportunities in the

market. At the same time, the government’s introduction to cdn acceleration test supportive policies and positive signals from the industry

have also creat a favorable environment for Aidikang’s development.

Judging from the performance of the capital market, a series of repurchase actions by company

executives are also using real money to enhance investor confidence.

According to Aidikang’s announcement on December 16, 2024

The company’s board of directors will use the repurchase authorization to repurchase no more than

36.2872 million shares in the open market, accounting mobile lead for approximately 5% of the total number of

shares issu as of the date of this announcement (excluding treasury shares, with a maximum

repurchase price of HK$9.69 per share. According to the exchange, Aidikang has launch a fivay repurchase from January 6 to 10, which further demonstrates the company’s firm confidence in its longterm development in the future and sends positive signals to the market As one of the pioneers.

Scroll to Top